Home › Pouchitis › North Carolina
Pouchitis clinical trials in North Carolina
3 studies for Pouchitis are looking for participants at sites in North Carolina.
Cities in North Carolina
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
- University of North Carolina, Chapel Hill
RecruitingPhase 4
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06312683Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT05938465Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
- University of North Carolina, Chapel Hill
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jan 30, 2026 · NCT06864403From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.